Kintara Therapeutics, Inc.

Seeking New Horizons for Cancer Patients

Kintara Therapeutics is dedicated to the development of novel cancer therapies for patients who are failing or resistant to current treatment regimens.

Learn How We are Making a Difference

Unlocking the Promise of Biology

Kintara Therapeutics has teamed up with outstanding academic and clinical research institutions from around the world to support the development of our novel solid tumor cancer therapies.

View Our Academic Collaborations

Late-Stage Therapeutic for Oncology Indication with Unmet Medical Need

REM-001 is a second-generation photosensitizer drug possessing multiple advantages over earlier generation PDT compounds.

Stock Information